Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial - Ziegler, R; Cavan, D A; Cranston, I (Diabetes Care, 2013)
et al.